FDA Classifies Insulin Therapy Adjustment Device into Class II with Special Controls

Summary

The FDA has classified the insulin therapy adjustment device into Class II with special controls, aiming to ensure its safety and effectiveness while reducing regulatory burdens and enhancing patient access to innovative devices.